Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The insulin resistance pathway via the PI3K-AKT signaling pathway is a central molecular cascade that mediates the effects of insulin on glucose and lipid metabolism. This pathway is crucial for maintaining glucose homeostasis, and its dysfunction is a key contributor to metabolic disorders such as obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. Impairment or inhibition of any step within this signaling cascade leads to reduced cellular response to insulin resulting in decreased glucose uptake into cells, increased hepatic gluconeogenesis, and enhanced lipolysis with elevated free fatty acids.
Drugs under investigation aim at restoring/enhancing PI3K/AKT activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Resistance Pathway via PI3K-AKT Signaling (PI3K-AKT Insulin Resistance Pathway).